
|
OUTER HOUSE, COURT OF SESSION [2005] CSOH 69 |
|
|
|
OPINION OF LORD NIMMO SMITH in the cause MRS MARGARET McTEAR Pursuer; against IMPERIAL TOBACCO LIMITED Defenders:
________________ |
Pursuer: McEachran, Q.C., Divers, Locke; Drummond Miller, W.S.
Defenders: Jones, Q.C., Wolffe; McGrigor Donald
31 May 2005
List of contents
[1.1] In view of the length of this Opinion, it may be helpful if at the outset I set out a list of its contents, by reference to its paragraph numbers, as follows:
|
Paragraph |
||
|
PART I: |
||
|
[1.2] |
||
|
[1.5] |
||
|
[1.11] |
||
|
[1.13] |
||
|
[1.30] |
||
|
[1.31] |
||
|
[1.32] |
||
|
[1.33] |
||
|
[1.35] |
||
|
PART II |
||
|
[2.1] |
||
|
[2.7] |
||
|
[2.10] |
||
|
[2.15] |
||
|
[2.23] |
||
|
[2.52] |
||
|
[2.54] |
||
|
[2.55] |
||
|
[2.62] |
||
|
[2.75] |
|
PART III: |
||
|
[3.2] |
||
|
[3.6] |
||
|
[3.11] |
||
|
[3.28] |
||
|
[3.45] |
||
|
[3.54] |
||
|
[3.58] |
||
|
[3.61] |
||
|
[3.63] |
||
|
[3.66] |
||
|
PART IV: |
||
|
[4.3] |
||
|
[4.67] |
||
|
[4.85] |
||
|
[4.95] |
||
|
[4.112] |
||
|
[4.124] |
||
|
[4.169] |
||
|
[4.174] |
||
|
[4.194] |
||
|
[4.200] |
||
|
[4.222] |
||
|
[4.226] |
||
|
PART V: |
||
|
[5.2] |
||
|
[5.12] |
||
|
[5.15] |
||
|
The evidence of expert witnesses: |
||
|
[5.20] |
||
|
[5.24] |
||
|
[5.27] |
||
|
[5.100] |
||
|
[5.184] |
||
|
[5.189] |
||
|
[5.211] |
||
|
[5.304] |
||
|
[5.305] |
||
|
[5.326] |
||
|
[5.339] |
||
|
[5.349] |
||
|
[5.370] |
||
|
[5.373] |
||
|
[5.435] |
||
|
[5.447] |
||
|
[5.448] |
||
|
[5.475] |
||
|
[5.480] |
||
|
[5.698] |
||
|
[5.739] |
||
|
[5.745] |
||
|
[5.766] |
||
|
[5.772] |
||
|
[5.829] |
||
|
[5.844] |
||
|
[5.847] |
||
|
[5.859] |
||
|
PART VI: |
||
|
[6.1] |
||
|
[6.2] |
||
|
[6.22] |
||
|
[6.24] |
||
|
[6.25] |
||
|
[6.30] |
||
|
[6.57] |
||
|
[6.149] |
||
|
[6.172] |
||
|
[6.186] |
||
|
[6.188] |
||
|
[6.194] |
||
|
[6.202] |
||
|
PART VII: |
||
|
[7.2] |
||
|
[7.19] |
||
|
[7.167] |
||
|
[7.182] |
||
|
[7.184] |
||
|
[7.185] |
||
|
[7.199] |
||
|
[7.204] |
||
|
PART VIII: |
||
|
[8.6] |
||
|
[8.14] |
||
|
[8.17] |
||
|
[8.19] |
||
|
PART IX: |
||
|
[9.1] |
||
|
[9.15] |
PART I: PRELIMINARIES
[1.2] Alfred McTear died, aged 48, on 23 March 1993. He and his wife, Mrs Margaret McTear, last lived together at 20 Cherrywood Drive, Beith, Ayrshire. He was the original pursuer in this action. After his death his wife, as his executrix-dative, was sisted as the pursuer in his room and place. For convenience I shall refer to them respectively as Mr McTear and Mrs McTear.
[1.3] The defenders are Imperial Tobacco Limited, whom I shall refer to as ITL. They manufacture, market and sell tobacco products in the United Kingdom, particularly cigarettes, including the John Player brand. They supply cigarettes to retail outlets throughout Scotland for onward sale to the public, and have done so for many years.
[1.4] Mr McTear died of lung cancer. In this action Mrs McTear claims that this was caused, at least to a material extent, by his smoking, from 1964 to 1992 cigarettes manufactured by ITL, and that throughout the period during which he smoked them ITL were negligent in selling cigarettes, or in any event in selling them without appropriate warnings, and she seeks an award of damages accordingly.
What the pursuer requires to prove
[1.5] The pursuer can succeed in this case only if she proves all of the following:
(1) that cigarette smoking can cause lung cancer;
(2) that cigarette smoking caused Mr McTear's lung cancer;
(3) that Mr McTear smoked cigarettes manufactured by ITL for long enough and in sufficient quantity for his smoking of their products to have caused or materially contributed to the development of his lung cancer;
(4) that Mr McTear smoked cigarettes manufactured by ITL because ITL were in breach of a duty of care owed by them to him; and
(5) that such breach caused or materially contributed to Mr McTear's lung cancer, either by making at least a material contribution to the exposure which caused his lung cancer or by materially increasing the risk of his contracting lung cancer.
Items (1) to (4) are as formulated by Mr Jones. Mr McEachran did not take issue with them. Item (5) takes account of counsel's submissions, discussed paras.[6.2] to [6.29].
[1.6] The burden of proving each of these matters rests on the pursuer. In order to discharge that burden, she must satisfy me, on the balance of probabilities, and on the basis of the evidence led before me and the applicable law, that each of these matters is proved.
[1.7] ITL plead, among other things, that Mr McTear willingly accepted as his own any risk to his health from smoking cigarettes; in doing this, they rely on the maxim volenti non fit iniuria, which I discuss below under that heading. The burden of proving this, on the balance of probabilities, is on ITL. ITL also plead that Mr McTear's illness was caused by his own fault or was contributed to by his fault, but at the hearing on evidence, Mr Jones did not invite me to sustain either of these pleas.
[1.8] I wish to state clearly now, and shall reflect this throughout my Opinion, that:
(1) This is in no sense a public inquiry into issues relating to smoking and health; it is a proof before answer in which I have to consider, having regard to the facts and the law, whether ITL should be found liable in damages to Mrs McTear.
(2) I must base my decision about questions of fact on the evidence, and that alone.
[1.9] Under our procedure, fair notice must be given by a party in the written pleadings (the final version of which is incorporated in the Closed Record) of any matter of fact about which the party may seek to lead evidence. Subject to the court's discretion to allow amendment at any stage (which may well be refused after a proof has started if it would seriously prejudice the other party) evidence may not be admitted of any matter of fact about which fair notice has not been given in this way.
[1.10] It must be emphasized that our system is evidence-based. My duty as a fact-finder is exactly the same as that of a jury, who in terms of their oath are bound to "give a true verdict according to the evidence". This brings me to a related topic.
Judicial knowledge
[1.11] On at least two occasions Mr McEachran made reference to judicial knowledge. The first was to suggest, at a By Order hearing before the proof, that it lay within judicial knowledge that cigarette smoking could cause lung cancer. The second was a suggestion, during the discussion of an objection at the proof, that the purpose and effect of advertising lay within judicial knowledge. Judicial knowledge must be distinguished from the personal knowledge of an individual judge. It is generally taken as relating to matters which can be immediately ascertained from sources of indisputable accuracy, or which are so notorious as to be indisputable, so that the judge is bound to take notice of them. If a matter does fall within judicial knowledge, a judge may refresh his memory or supplement his knowledge regarding it by consulting recognised works of reference, such as dictionaries or textbooks. Apart from the matters which are recognised as being within judicial knowledge, it is improper for a judge to proceed upon personal knowledge of the facts in issue, or upon personal examination of passages in textbooks. For a discussion of this, and reference to authorities vouching the foregoing proposition, see Walkers on Evidence (2nd edn., 2000), pp.171-3, para.11.6.
[1.12] No doubt, where there is an issue of general public importance, a judge may have views about it in his or her private capacity. But it is an essential part of the judicial function that these views be put out of mind when hearing a case: otherwise, the judge would simply be at risk of pre-judging the very issue upon which he or she may be called to make a decision judicially. One of the fundamental issues in this case is whether cigarette smoking can cause lung cancer. This is an issue which I am duty-bound to approach with an open mind and to decide on the basis of the evidence led before me. As with all other disputed issues of fact, the burden of proof is on the party who seeks to establish this, in this instance on the pursuer.
[1.13] It is appropriate at this stage to refer to some of the procedural events which have taken place in this action and in a related application for judicial review by Mrs McTear.
[1.14] A claim was intimated on behalf of Mr McTear in July 1992. In early January 1993 an application for legal aid on behalf of Mr McTear was submitted to the Scottish Legal Aid Board for legal aid to fund the conduct of litigation on his behalf. In the application form it was stated that legal aid was sought to raise an action against "Richard Lloyd & Sons (who manufacture Old Holborn tobacco) and John Player & Sons (who manufacture John Players [sic] cigarettes)".
[1.15] The summons in the present action was signeted on 28 January 1993, and was presumably served shortly thereafter. On 3 March 1993 an interlocutor was pronounced granting commission to Mr Bolland, Q.C. to take the evidence of Mr McTear at a time and place to be appointed by the Commissioner. On 16 March 1993 at his home address, 20 Cherrywood Drive, Beith, Ayrshire, Mr McTear was duly sworn, and was examined in chief by his senior counsel, Mr McEachran, Q.C. On the same day Mr Hodge, who acted at that time as junior counsel for ITL, began his cross-examination of Mr McTear. As subsequently reported by the Commissioner, the commission was adjourned in mid-afternoon on that day "due to a deterioration in [Mr McTear's] condition and consequent inability to deal with questions". This followed advice from Mr McTear's general medical practitioner, who examined him at lunch-time. The next day, 17 March, Mr Hodge continued his cross-examination, but after approximately an hour and a half the Commissioner adjourned the commission in order to have Mr McTear medically examined. The view was then taken that Mr McTear was unable to continue giving evidence that day. An attempt was made to reconvene the commission on 19 March, but the doctor's advice was that Mr McTear was unable to resume giving evidence that day. That remained the position until he died on 23 March. At the point when the commission was adjourned on 17 March, Mr Hodge was, as he informed the Commissioner, about to put more contentious questions designed to test credibility and reliability. In the event, these questions were never put to Mr McTear. It appears, therefore, that most of the intended cross-examination was unable to take place. In his supplementary report, the Commissioner explained that he did not consider it appropriate to offer a view on the credibility and reliability of Mr McTear in relation to part of his evidence and not the whole, so he was unable to comply with a request to do so.
[1.16] A transcript of the evidence given by Mr McTear on commission, so far as it went, is available to me and forms part of the evidence in the case. Most of his evidence in chief was read out at the beginning of the proof before me, and in due course Mr McEachran sought to rely on certain passages in it. For reasons which I discuss in detail below, Mr Jones submitted that I should find Mr McTear's evidence to have been incredible and unreliable in certain material respects. I shall therefore have to make an assessment of this evidence as best I can, bearing in mind that it was given by a dying man, and one whose demeanour I have not had the opportunity of observing for myself.
[1.17] On 24 September 1993 the action was sisted pending determination of an application by Mrs McTear to the Scottish Legal Aid Board for civil legal aid to enable her to pursue the action. The tests which required to be satisfied in order for her application to succeed were as set out in section 14 (1) of the Legal Aid (Scotland) Act 1986, which provides inter alia:
"[C]ivil legal aid shall be available to a person if, on an application made to the Board -
(a) the Board is satisfied that he has a probabilis causa litigandi; and
(b) it appears to the Board that it is reasonable in the particular circumstances of the case that he should receive legal aid."
Mrs McTear's application was refused as unreasonable by the Board. An application to the Board for review of that decision was also refused. Mrs McTear then applied to this court for judicial review of the Board's decision, alleging that it had acted unreasonably in refusing the application. After a first hearing, at which Mrs McTear and the Board were represented by counsel, the Lord Ordinary, Lord Kirkwood, by interlocutor dated 15 February 1995 dismissed the petition. There was no appeal against Lord Kirkwood's decision. The full history of the matter, including the reasons given by the Board and by Lord Kirkwood for their respective decisions, can be found in the report McTear v Scottish Legal Aid Board 1995 S.C.L.R. 611.
[1.18] At one stage of the procedural discussions before me, when preparations for the proof were being reviewed, Mr McEachran suggested that I might write to the Board, expressing the view that Mrs McTear should be granted legal aid. I declined to do this, because it is not my function to enter into such correspondence, and the appropriate occasion for the court to express its views is when disposing of an application for judicial review of a decision of the Board, as had already happened in the present case. Even then, as explained by Lord Kirkwood, the court cannot substitute its own view on the merits of the application for that reached by the Board, unless the latter had arrived at a perverse or unreasonable decision.
[1.19] As I understand it, counsel and solicitors representing Mrs McTear have conducted this action of her behalf on a speculative ("no win, no fee") basis. Reference will be made hereafter to the voluntary organisations Action on Smoking and Health (ASH) and ASH Scotland. At this stage, I should say that I believe it to be the case that ASH Scotland is in general supportive of the present action, but at no time has given any financial support for it.
[1.20] In these circumstances, ITL enrolled a motion to ordain Mrs McTear to find caution for expenses (in English procedure, security for costs) in respect of the following factors:
"(1) The nature, scale and cost of the litigation, (2) the apparent inability of the pursuer to meet the expenses liable to arise, (3) the refusal of legal aid to the pursuer, (4) the pursuer's limited prospects of success, (5) the small value of the claim, (6) the fact that the action had been raised in the interests of persons other than the pursuer, (7) the delay in arranging to take Mr McTear's evidence on commission, and (8) the unavailability to the defenders of other protective remedies."
On 9 April 1996 Lord Gill refused this motion. In his Opinion, he said that the sixth factor was the aspect of the case that had troubled him most. He referred to newspaper cuttings and broadcast transcripts. These indicated that the pursuer's Glasgow solicitors, Ross Harper who originally acted for Mr McTear, had been "fairly accessible to the media on the subject of this case". It appeared from statements made by these solicitors that they had established a special claims unit to deal with similar claims and had numerous similar actions to follow on this one. According to a broadcast transcript, a partner in the firm, Mr Cameron Fyfe, said that "the world is watching this case" and predicted that if it were to succeed it would "open the floodgates to thousands of others, not only in Scotland, but interestingly in the western world". In addition, Lord Gill said, there had been numerous reports that the present action was being "backed" by an "anti-smoking pressure group", ASH, one of whose spokesmen was reported to have said, with reference to this action, "we just need one breakthrough, we just need one victory. [...] We just have to win one case to win everything". Lord Gill said, at pp.20-21:
"From the many published comments on this case I can see why the defenders should have been concerned by the possibility that this action may have been brought primarily for the benefit of third parties. However, I have an assurance from senior counsel for the pursuer [Mr McEachran] that this concern is unfounded and that, whatever implications the action may have for third party onlookers, the pursuer is genuinely suing it on her own behalf and in her own interests, as executrix and widow, with the serious purpose of recovering damages in both of these capacities.
I also inferred from senior counsel's comments that, whatever impression may have been given in the media as to the extent of their involvement, ASH are contributing to the action no more than their enthusiastic moral support.
It may well be that third parties will benefit in various ways if this action succeeds; but that will always be the case where a cause of action is common to numerous claimants, for example relatives of disaster victims, or where an action raises the question of general public importance, for example the safety of a medicine or of a consumer product.
On the basis of the assurance given to me, I am not willing to grant the motion on this ground."
[1.21] On 19 July 1996 an Extra Division refused a reclaiming motion against Lord Gill's decision. It was held that he had not misdirected himself and was not plainly wrong. Notwithstanding this, the information provided to Lord Gill and on the basis of which he refused the motion may bear re-examination in light of subsequent events.
[1.22] The case thereafter called in the procedure roll before Lord McCluskey. The purpose of the debate was to determine which of the pursuer's averments should be allowed to go to proof. On 23 October 2001 Lord McCluskey allowed a proof under deletion of certain averments. Subject to this, he reserved all pleas and allowed the parties a proof before answer in respect of the averments that remained. It was on the basis of these averments that the parties made, or should have made, their preparations for the conduct of the case at the proof.
[1.23] After being nominated in 2003 as the judge before whom the proof was to take place, I held a number of By Order hearings to discuss the state of the parties' preparations for the conduct of the proof and to decide any incidental motions.
[1.24] One such motion was at the instance of ITL on a commission and diligence for recovery of documents called for in a specification of documents. After hearing counsel, I granted diligence against havers so far as related to call 1, which was amended at the bar. In brief, this call related to documents showing or tending to show (under deletion of any entry naming or enabling any third party to identify any subject or subjects of the studies)
(a) the data sets (including the baseline data for the subjects, all follow-up points and all outcome points thereof and the full descriptions of data files and all variables (including generated variables) within the data sets) for the British Doctors' Study or studies reported in six papers published between 1954 and 1977, of which Professor Sir Richard Doll, one of the expert witnesses for Mrs McTear, was a joint author;
(b) the age distribution and any other characteristics of the general population used for the purposes of the analysis reported in said papers;
(c) the statistical methods employed in the analysis of the data presented in said papers; and
(d) the statistical programmes used to perform the said analysis or analyses.
I am not aware that any documents falling within the terms of this call were among the productions for either party. I am not aware of the reason or reasons for this outcome.
[1.25] As has been apparent throughout, ITL have been prepared to devote considerable resources to the defence of this action. Its outcome is no less important for them than it is for the pursuer and the "third party onlookers". While the respective positions of the parties have thus been very unequal, I see no reason at all to treat this as a criticism of ITL. They are fully entitled to defend their interests as they have done, and, despite occasional complaints by Mr McEachran, there has been no point at which in my view they have unnecessarily protracted the proceedings or have otherwise resorted to tactics designed to exploit Mrs McTear's lack of funds. The inequality is an unavoidable consequence of the decision to continue with the conduct of the action without the benefit of legal aid or any other source of financial support.
[1.26] At one hearing before the proof, Mr McEachran advanced a motion, in terms similar to those of one which had previously been heard and refused by Lord Carloway, that I should restrict the number of days during which evidence would be led at the proof, and restrict the number of expert witnesses to be called on behalf of ITL. I refused this motion on the basis that I had no power to grant it and in any event because I could see no justification for it on the information then available to me. I indicated, however, that there would be scope for intervention during the course of the proof if it appeared that ITL were unnecessarily duplicating evidence or otherwise protracting the proceedings. In the event, as I have said, this did not happen.
[1.27] While there can be little doubt that the case for Mrs McTear would have been conducted differently had more resources been available, Mr McEachran accepted in his closing submissions that it was not open to me to take any account of this in reaching my decision.
[1.28] I emphasise, therefore, that my decision must, in accordance with our usual rules, be based solely on the parties' written pleadings, on the evidence led before me and on the submissions of counsel thereon, subject to the application of the law as I find it to be.
[1.29] The proof itself was conducted in accordance with our usual procedure. What was of great assistance was the use of modern systems. The documentary productions, on an estimate I have been given, extended to about 85,000 pages. At least four sets of paper copies would have been required for use in court; and experience shows how difficult this would have been to manage, and how much time would have been lost, had paper been used. Instead, all the documents were scanned into an electronic database, and the system was operated in court by an operator who was able on request to cause any page to be displayed on screens for all the participants to see. The evidence of witnesses and the submissions of counsel were transcribed by two operators using the LiveNote system, which produced an almost instantaneous transcript on separate screens with a high initial degree of accuracy. The transcript was thereafter edited, so that by the start of the next day's business there were very few remaining errors. Though there were occasions when paper was used for various reasons, the proof was in general conducted on a paperless basis. All of this was provided at the expense of ITL. I regard it as money well spent. I am confident that much time was saved, compared with the use of paper. The evidence of witnesses took thirty days, and counsel's submissions took twelve days. On reviewing the transcript, and the documents which were referred to by witnesses and counsel, I am struck by how much was covered in that time. The use of paper, traditional methods of note-taking, and so on, would have significantly added to the length of the proceedings, and the difficulties of my subsequent task in preparing this Opinion.
Published materials
(1) Legal authorities
[1.30] The following cases and legal textbooks are referred to in this Opinion. Some cases not listed here were mentioned in counsel's written submissions, but not at the hearing on evidence, and I see no need to include them. Since there will be readers of this Opinion who are not lawyers, do not have access to law libraries and are not familiar with the case law, I have decided, where reference is first made to a case, to set out the summary of it from the rubric or headnote in the report, so as to provide some context for the quotations of passages from the opinions or judgments which follow. The quotations are assemblies of all the passages referred to by counsel, albeit at different times.
[1.31] Bogle v McDonald's Restaurants Ltd [2002] E.W.H.C. 490 (Q.B.)
Bow Valley Husky (Bermuda) Ltd v Saint John Shipbuilding Ltd [1997] 3 S.C.R. 1210
Cruz-Vargas v R.J. Reynolds Tobacco Company 348 F.3d 271 (1st Cir.2003)
Davie v Magistrates of Edinburgh 1953 S.C. 34
Dingley v The Chief Constable, Strathclyde Police 1998 S.C. 548, 2000 S.C. (H.L.) 77
Donoghue v Stevenson 1932 S.C. (H.L.) 31
Elf Caledonia Ltd v London Bridge Engineering Ltd, 2 September 1997
Fairchild v Glenhaven Funeral Services Ltd [2003] 1 A.C. 32
Fowler v Tierney 1974 S.L.T. (Notes) 23
Galbraith v HM Advocate (No.2) 2002 J.C. 1
Graham Barclay Oysters Pty Ltd v Ryan (2002) 211 C.L.R. 540
Grant v Australian Knitting Mills Ltd [1936] A.C. 85
Hamilton v Fife Health Board 1993 S.C. 369
Heine v Reemtsma Cigarettenfabriken GmbH 2 O 294/02
Hodge & Sons v Anglo-American Oil Co (1922) 12 Ll.L.R. 183
Holmes v Ashford [1950] 2 All.E.R. 76
Hotson v East Berkshire Area Health Authority [1987] A.C. 750
Imperial Chemical Industries Ltd v Shatwell [1965] A.C. 656
Law Hospital NHS Trust v Lord Advocate 1996 S.C. 301
Letang v Ottawa Electric Railway Co [1926] A.C. 725
Lewis v University of Bristol [1999] E.W.C.A. Civ. 1569
Létourneau v Imperial Tobacco Ltd (1998) 162 D.L.R. (4th) 734
London Graving Dock Co Ltd v Horton [1951] A.C. 737
Lund v J.L. Tiedemanns Tobaksfabrik A.S., H.R. - 2002 - 00753a, 31 October 2003
McCaig v Langan 1964 S.L.T. 121
McGhee v National Coal Board 1973 S.C. (H.L.) 37
McKillen v Barclay Curle & Co Ltd 1967 S.L.T. 41
McLean v William Denny & Bros Ltd 2004 S.L.T. 422, 2004 S.C. 656
McManus's Executrix v Babcock Energy Ltd 1999 S.C. 569
McTear v Scottish Legal Aid Board 1995 S.C.L.R. 611
McWilliams v Sir William Arrol & Co 1962 S.C. (H.L.) 70
Main v Andrew Wormald Ltd 1988 S.L.T. 141
Morris v Murray [1991] 2 Q.B. 6
Murphy v Brentwood District Council [1991] 1 A.C. 398
Murray's Executrix v Greenock Dockyard Co Ltd 2004 S.L.T. 346, 2004 S.L.T. 1104
Nettleship v Weston [1971] 2 Q.B. 691
National Justice Compania Naviera S.A. v Prudential Assurance Co. Ltd ("The Ikarian Reefer") [1993] 2 Lloyd's Rep.68
Overseas Tankship (UK) Ltd v Morts Dock & Engineering Co Ltd (The Wagon Mound) [1961] 1 A.C. 388
Paugh v R.J. Reynolds Tobacco Company 834 F.Supp. 228 (N.D.Ohio 1993)
Pelman v McDonald's Corporation 237 F.Supp.2d 512 (S.D.N.Y.2003)
John Pierce v Her Majesty's Advocate 1981 S.C.L.R. 783
R. v Abadom [1983] 1 W.L.R. 126
Reeves v Commissioner of Police of the Metropolis [2000] 1 A.C. 360
Rhesa Shipping Co S.A. v Edmunds [1985] 1 W.L.R. 948
Roysdon v R.J. Reynolds; Roysdon v R.J. Reynolds Tobacco Company 849 F.2d 230 (6th Cir. 1988)
Shaher v British Aerospace Flying College Ltd 2003 S.C. 540
Thompson v Johnson and Johnson Pty Ltd [1991] 2 V.R. 449
Thompson v Smith's Shiprepairers (North Shields) Ltd [1984] 1 Q.B. 405
Titchener v British Railways Board 1984 S.C. (H.L.) 34
Tompkin v American Brands 219 F.3d 566 (6th Cir. 2000)
Tomlinson v Congleton Borough Council [2004] 1 A.C. 46
Wardlaw v Bonnington Castings Ltd 1956 S.C. (H.L.) 26
Watson v Fram Reinforced Concrete Co (Scotland) Ltd 1960 S.C. (H.L.) 92
White v Blackmore [1972] 3 All.E.R. 158
Winnik v Dick 1984 S.L.T. 185
Wilsher v Essex Area Health Authority [1988] A.C. 1074
Wright v Dunlop Rubber Co Ltd (1972) 13 K.I.R. 255
Woods v Multi-Sport Holdings Pty Ltd (2002) 208 C.L.R. 460
[1.32] Lewis, Manual of the Law of Evidence in Scotland (1925)
Salmond & Heuston, The Law of Torts, 21st ed. (1996), p.296
Walkers on Evidence (2nd edn., 2000)
Wilkinson, The Scottish Law of Evidence (1986)
(2) Non-legal publications
[1.33] I have decided to incorporate in this Opinion a list of references to all the publications, other than cases reported in law reports, which were discussed in the course of evidence and counsel's submissions. Following the general practice adopted by the expert witnesses in their written reports, I shall use the author-date (Harvard) system of reference. Where authorship is attributed to an organisation, rather than to an individual or individuals, I have used an acronym. In most instances, where evidence was given under reference to a passage in a publication, the passage in question was displayed on screens in court. My quotations of such passages have been checked against the original texts as then on view. In a very few instances witnesses in reading from their written reports gave quotations from publications without direct reference being made to the original texts. In these instances I have thought it best to give the author-date references and to check the quotations against the original texts. In general, however, it may be taken that where an author-date reference is given and a text is quoted, the original text was under discussion in the course of evidence. On occasions, witnesses gave evidence about publications without being asked to refer to the original texts. Such publications are in most cases not included in this list of references, and I have attempted to distinguish them from those which are by separating the authors' names from dates by one or more words; i.e. author-date references in the text are to publications included in the list and, except in a few cases where convenience dictated otherwise, no publication is included in the list unless reference was made to the original text at the proof.
[1.34] The citations in the list of references which follows are as complete and accurate as I can make them and are in a style which I believe to be generally acceptable.
|
ACC 1981: American Cancer Society. Cancer Facts & Figures 1982. New York: American Cancer Society, 1981. |
|
Adler I. Primary malignant growths of the lungs and bronchi. London: Longmans, Green & Co, 1912. |
|
Alavanja MCR, Brownson RC, Boice JD Jr, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992; 136: 623-632. |
|
Anonymous. Cancer of the lung [editorial]. Brit Med J 1942: 672-673. |
|
Anonymous. Tobacco and lung cancer [editorial]. Lancet 1950; 2: 257-258. |
|
Anonymous. An unexpected new human virus [editorial]. Lancet 1986; 328: 1430-1431. |
|
Auerbach O. The pathology of carcinoma of the bronchus. N Y State J M 1949; 49: 900-907. |
|
Auerbach O, Garfinkel L. The changing pattern of lung carcinoma. Cancer 1991; 68: 1973-1977. |
|
Auerbach O, Garfinkel L, Parks VR. Histologic type of lung cancer in relation to smoking habits, year of diagnosis and sites of metastases. Chest 1975; 67: 382-387. |
|
Auerbach O, Gere JB, Forman JB, Petrick TG, Smolin HJ, Muehsam GE, Kassouny DY, Stout AP. Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med 1957; 17: 97-104. |
|
Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961; 265: 253-267. |
|
Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer: A review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2001; 10: 813-821. |
|
Barnard WG. The nature of the "oat-celled sarcoma" of the mediastinum. J Path 1926; 29: 241-244. |
|
Bennett WP, Hussain P, Vahakangas KH, Khan MA, Shields PG, Harris CC. Molecular epidemiology of human cancer risk: Gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 1999; 187: 8-18. |
|
Berkson J. Smoking and lung cancer: Some observations on two recent reports. Med Proc 1959; 5: 442-449. |
|
Berkson J. Statistics and tobacco [letter]. JAMA 1960; 172: 967-969. |
|
Berkson J. Smoking and lung cancer. Med Proc 1964; 10: 327-336. |
|
Bernfeld P, Homburger F, Russfield AB. Strain differences in the response of inbred Syrian hamsters to cigarette smoke inhalation. J Natl Cancer Inst 1974; 53: 1141-1157. |
|
Bernfeld P, Homburger F, Soto E, Pai KJ. Cigarette smoke inhalation studies in inbred Syrian golden hamsters. J Natl Cancer Inst 1979; 63: 675-689. |
|
Biroš E, Kalina I, Kohút A, Štubňa J, Šalagovič J. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer 2001a; 31: 157-162. |
|
Biroš E, Kalina I, Biroš I, Kohút A, Bogyiová E, Šalagovič J, Štubňa J. Polymorphism of the p53 gene within the codon 72 in lung cancer patients. Neoplasma 2001b; 48: 407-411. |
|
Bonser GM. The incidence of tumours of the respiratory tract in Leeds. J Hygiene 1929; 28: 340-354. |
|
Booker WM. Statement in: Comprehensive Smoking Prevention Education Act. Appendix to hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 97th Congress. Serial No.97-107, 572-575. Washington DC: U.S. Government Printing Office, 1982. |
|
Boutwell RK. Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 1964; 4: 207-250. |
|
Boyd MA. Cancer of bronchial glands and lung. Trans Acad Med Ireland 1886; 4: 91-99. |
|
Boyland E. Different types of carcinogens and their possible modes of action: A review. Cancer Res 1952; 12: 77-84. |
|
Brownlee KA. A review of "Smoking and Health" [USSG 1964]. J Am Stat Assoc 1965; 60: 722-739. |
|
BTS 1990: Research Committee of the British Thoracic Society. Smoking cessation in patients: Two further studies by the British Thoracic Society. Thorax 1990; 45: 835-840. |
|
Burch PRJ. Genetic carrier frequency for lung cancer. Nature 1964; 202: 711-712. |
|
Burch PRJ. Does smoking cause lung cancer? New Scientist 1974a; 61: 458-463. |
|
Burch PRJ. Smoking and lung cancer: Burch's reply. New Scientist 1974b; 61: 559-560. |
|
Burch PRJ. Smoking and cancer [letter]. New Scientist 1974c; 61: 837. |
|
Burch PRJ. Smoking and cancer [letter]. New Scientist 1974d; 62: 195. |
|
Burch PRJ. Problems in the interpretation of cancer statistics with special reference to lung cancer. J Soc Occup Med 1975; 25: 2-10. |
|
Burch PRJ. Smoking and lung cancer: The problem of inferring cause [with discussion by other contributors]. J R Statist Soc 1978; 141: 437-477. |
|
Burch PRJ. The Surgeon General's "epidemiologic criteria for causality": A critique. J Chron Dis 1983; 36: 821-836. |
|
Callum C. The UK smoking epidemic: Deaths in 1995. London: Health Education Authority, 1998. |
|
Carnow BW. The "urban factor" and lung cancer: Cigarette smoking or air pollution? Environ Health Perspect 1978; 22: 17-21. |
|
Chang M, Hahn RA, Teutsch SM, Hutwagner LC. Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. Journal of Clinical Epidemiology 2001; 54: 634-644. |
|
Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 2003; 97: 1558-1563. |
|
Colby TV, Koss MN, Travis WD. "Tumors of the lower respiratory tract." In: Atlas of Tumor Pathology (3rd series, fascicle 13). Washington DC: Armed Forces Institute of Pathology, 1995; 91-106. |
|
Cole P, Merletti F. Chemical agents and occupational cancer. Journal of Environmental Pathology and Toxicology 1980; 3: 399-417. |
|
Crofton J, Simpson D. Tobacco: A global threat. Oxford: Macmillan Publishers Ltd, 1992. |
|
CTR 1984: The Council for Tobacco Research - USA, Inc. Final report of research performed under contract entitled "Smoke inhalation studies in mice" between Microbiological Associates, Bethesda, Maryland and The Council for Tobacco Research - USA, Inc. New York: Field, Rich & Associates, Inc., 1984. |
|
Dalbey WE, Nettesheim P, Griesemer R, Caton JE, Guerin MR. Chronic inhalation of cigarette smoke by F344 rats. J Natl Cancer Inst 1980; 64: 383-390. |
|
Darby S, Whitley E, Doll R, Key T, Silcocks P. Diet, smoking and lung cancer: A case-control study of 1000 cases and 1500 controls in South-West England. Br J Cancer 2001; 84: 728-735. |
|
Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of Benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 1996; 274: 430-432. |
|
Denissenko MF, Chen JX, Tang MS, Pfeifer GP. Cytosine methylation determines hot spots of DNA damage in the human p53 gene. Proc Natl Acad Sci USA 1997; 94: 3893-3898. |
|
Doll R. Bronchial carcinoma: Incidence and aetiology. Br Med J 1953; 2: 521-527. |
|
Doll R. Smoking, lung cancer and Occam's razor. New Scientist 1974; 61: 463, 466-467. |
|
Doll R. An overview of the epidemiological evidence linking diet and cancer. Proc Nutr Soc 1990; 49: 119-131. |
|
Doll R. Tobacco: A medical history [biennial lecture delivered at Green College, Oxford, 1997]. In: UKHC 2000, Vol.II; 19-35. |
|
Doll R. Uncovering the effects of smoking: Historical perspective. Stat Methods Med Res 1998; 7: 87-117. |
|
Doll R. How it really happened: Smoking and lung cancer. Am J Respir Crit Care Med 2000; 162: 4-6. |
|
Doll R. Proof of causality: Deduction from epidemiological observation. Perspect Biol Med 2002; 45: 499-515. |
|
Doll R, Hill AB. Smoking and carcinoma of the lung: Preliminary report. Br Med J 1950; 2: 739-748. |
|
Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: A preliminary report. Br Med J 1954; 1: 1451-1455. |
|
Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; 2: 1525-1536. |
|
Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 1994; 309: 901-911. |
|
Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001; 92: 144-150. |
|
Dontenwill W, Chevalier H-J, Harke H-P, Lafrenz U, Reckzeh G, Schneider B. Investigations on the effects of chronic cigarette smoke inhalation in Syrian golden hamsters. J Natl Cancer Inst 1973; 51: 1781-1832. |
|
Dontenwill W, Chevalier H-J, Harke H-P, Klimisch H-J, Kuhnigk C, Reckzeh G, Schneider B. Studies on the effect of chronic cigarette smoke inhalation in Syrian golden hamsters and the importance of vitamin A on morphological alterations after smoke exposure [title translated from German]. Z Krebsforsch 1977; 89: 153-180. |
|
DSM-IV. Diagnostic and statistical manual of mental disorders: Fourth edition: Text revision. Washington DC: American Psychiatric Association, 2000. |
|
Enstrom JE, Kabat GC. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98. Br Med J 2003; 326: 1057-1061. |
|
Eysenck HJ. Smoking, health and personality. New York: Basic Books, Inc., 1965. |
|
Eysenck HJ. Statement in: Comprehensive Smoking Prevention Education Act. Appendix to hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 97th Congress. Serial No.97-106, 443-446. Washington DC: U.S. Government Printing Office, 1982. |
|
Eysenck HJ. Statement in: Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 98th Congress. Serial No.98-8, 442-449. Washington DC: U.S. Government Printing Office, 1983. |
|
Eysenck HJ, Tarrant M, Woolf M, England L. Smoking and personality. Br Med J 1960; 1456-1460. |
|
Falk HL, Kotin P, Thompson S. Inhibition of carcinogenesis: The effect of polycyclic hydrocarbons and related compounds. Arch Environ Hlth 1964; 9: 169-179. |
|
Feron VJ, Groten JP, van Bladeren PJ. Exposure of humans to complex chemical mixtures: Hazard identification and risk assessment. Arch Toxicol 1998; 20: 363-373. |
|
Fisher RA. Smoking: The cancer controversy. Edinburgh: Oliver and Boyd, 1959. |
|
Fletcher CM. Cigarette smoking and the prevention of lung cancer [with discussion by Hueper WC]. Cancer Documen and Stat of Malig Tumors 1966; 183-192. |
|
Fletcher CM. Journal interview 30: Conversation with Charles Fletcher. British Journal of Addiction 1992; 87: 527-538. |
|
Frenk H, Dar R. A critique of nicotine addiction. New York: Kluwer Academic Publishers, 2000. |
|
Fried BM. Bronchiogenic carcinoma and adenoma. Baltimore: The Williams & Wilkins Co, 1948. |
|
Friend JAR. Children and smoking [editorial]. British Journal of Hospital Medicine 1991; 46: 77. |
|
Furst A. Statement in: Comprehensive Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 97th Congress. Serial No.97-106, 511-513. Washington DC: U.S. Government Printing Office, 1982. |
|
Gauderman WJ, Morrison JL, Carpenter CL, Thomas DC. Analysis of gene-smoking interaction in lung cancer. Genetic Epidemiology 1997; 14: 199-214. |
|
Gilliam AG. Trends of mortality attributed to carcinoma of the lung: Possible effects of faulty certification of deaths to other respiratory diseases. Cancer 1955; 8: 1130-1136. |
|
Gillis CR, Hole DJ, Boyle P. Cigarette smoking and male lung cancer in an area of very high incidence: I. Report of a case-control study in the West of Scotland. J Epidemiol Community Health 1988a; 42: 38-43. |
|
Gillis CR, Hole DJ, Hawthorne VM. Cigarette smoking and male lung cancer in an area of very high incidence: II. Report of a general population cohort study in the West of Scotland. J Epidemiol Community Health 1988b; 42: 44-48. |
|
Goldstein LS. To BaP or not to BaP? That is the question [editorial]. Environ Hlth Perspec 2001; 109; 356-357. |
|
Gori GB. Epidemiology and the concept of causation in multifactorial diseases. Regulatory Toxicology and Pharmacology 1989; 9: 263-272. |
|
Gorski A, Castronovo V, Stepien-Sopniewska B, Grieb P, Ryba M, Mrowiec T, et al. Depressed immune surveillance against cancer: Role of deficient T cell: Extracellular matrix interactions. Cell Adhesion Communication 1994; 2: 225-233. |
|
Gray JA, Mitchell SN, Joseph MH, Grigoryan GA, Dawe S, Hodges H. Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Devel Res 1994; 31: 3-17. |
|
Greenland S. "Probability versus Popper: An elaboration of the insufficiency of current Popperian approaches for epidemiologic analysis." In: Rothman KJ. Causal inference. Chestnut Hill: Epidemiology Resources Inc., 1988; 95-104. |
|
Hainaut P, Pfeifer GP. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22: 367-374. |
|
Hart CL, Hole DJ, Gillis CR, Davey Smith G, Watt GCM, Hawthorne VM. Social class differences in lung cancer mortality: Risk factor explanations using two Scottish cohort studies. Int J Epidemiol 2001: 30; 268-274. |
|
Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Nakagawa K, Hayashi J, Tsuchiya E. Different subtypes of human lung adenocarcinoma caused by different etiological factors: Evidence from p53 mutational spectra. Am J Pathol 2000; 157: 2133-2141. |
|
Hastings GB, Stead M, Whitehead M, Lowry R, MacFadyen L, McVey D, Owen L, Tones K. Using the media to tackle the health divide: Future directions. Social Marketing Quarterly 1998; 4: 42-67. |
|
Hein HO, Suadicani P, Gyntelberg F. Lung cancer risk and social class: The Copenhagen Male Study - 17-year follow up. Danish Medical Bulletin 1992; 39: 173-176. |
|
Henningfield JE. Pharmacologic basis and treatment of cigarette smoking. J Clin Psychiat 1984; 45: 24-34. |
|
Herman B, Rao MS. Lung cancer among the Jews and non-Jews of Pittsburgh, Pennsylvania, 1953-1967: II. Medical care initiation and diagnostic procedures. Am J Epidemiol 1971; 94: 11-15. |
|
Herrold KM. Survey of histologic types of primary lung cancer in U.S. veterans. Pathology Annual 1972; 7: 45-79. |
|
Hickey RJ. Statement in: Comprehensive Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 97th Congress. Serial No.97-107, 618-626. Washington DC: U.S. Government Printing Office, 1982. |
|
Hill AB. Principles of medical statistics (8th edn.). New York: Oxford University Press, 1966. |
|
Hindmarch I. "Is tobacco smoking an addiction?" In: Coresta Congress 1998 Information Bulletin. Brighton: Coresta, 1998; 22-29. |
|
Hinshaw HC, Garland LH. Diseases of the Chest (2nd edn.). Philadelphia: WB Saunders Co, 1963. |
|
Horne RL, Picard RS. Psychosocial risk factors for lung cancer. Psychosomatic Medicine 1979; 41: 503-514. |
|
Horsfall FL. Unifying concept of the origin of cancer. Med Clin N Amer 1966a; 50: 869-874. |
|
Horsfall FL. Cancer and viruses. Bull NY Acad Med 1966b; 42: 167-181. |
|
Hsieh CC, Walter SD. The effect of non-differential exposure misclassification on estimates of the attributable and prevented fraction. Stat Med 1988; 7: 1073-1085. |
|
IARC 1980: World Health Organization International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Supplement 2. Long-term and short-term screening assays for carcinogens: A critical appraisal. Lyon: IARC, 1980. |
|
IARC 1986: World Health Organization International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol.38. Tobacco smoking. Lyon: IARC, 1986. |
|
IARC 2004: World Health Organization International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol.83. Tobacco smoke and involuntary smoking. Lyon: IARC, 2004. (Part 5, "Summary of data reported and evaluation", and relative press release, published in 2002.) |
|
ICD-10: World Health Organization. Nomenclature and classification of drug- and alcohol-related problems: A WHO memorandum, 10th revision. Geneva: WHO, 1992. |
|
Jaffe RH. The primary carcinoma of the lung: A review of 100 autopsies. J Lab Clin Med 1934; 20: 1227-1237. |
|
James DS, Leadbeatter S, Knight B. Smoking accepted on death certificates [letter]. Br Med J 1992; 305: 830. |
|
Johnson CR, Clagett OT, Good CA. The importance of exploratory thoracotomy in the diagnosis of certain pulmonary lesions. Surgery 1949; 25: 218-230. |
|
Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: A causal analysis. Arch Gen Psychiat 1993; 50: 36-43. |
|
Kissen DM. Aspects of personality of men with lung cancer. Acta Psychother 1963a; 11: 200-210. |
|
Kissen DM. Personality characteristics in males conducive to lung cancer. Br J Med Psychol 1963b; 36: 27-36. |
|
Kissen DM, Rao LGS. Steroid excretion patterns and personality in lung cancer. Ann NY Acad Sci 1969; 164: 476-482. |
|
Knekt P, Raitasalo R, Heliövaara M, Lehtinen V, Pukkala E, Teppo L, Maatela J, Aromaa A. Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol 1996; 144: 1096-1103. |
|
Krawczak M, Cooper DN. p53 mutations, Benzo[a]pyrene and lung cancer. Mutagenesis 1998; 13: 319-320. |
|
Kripke ML. Immunoregulation of carcinogenesis: Past, present, and future. J Natl Cancer Inst 1988; 80: 722-727. |
|
Kupper LL. Statement in: Comprehensive Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 97th Congress. Serial No.97-107, 647-656. Washington DC: U.S. Government Printing Office, 1982. |
|
Langston HT. Statement in: Comprehensive Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 97th Congress. Serial No.97-107, 657-663. Washington DC: U.S. Government Printing Office, 1982. |
|
Langston HT. Statement in: Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 98th Congress. Serial No.98-8, 449-463. Washington DC: U.S. Government Printing Office, 1983. |
|
Laroye GJ. How efficient is immunological surveillance against cancer and why does it fail? Lancet 1974; i: 1097-1100. |
|
Lennox AS, Osman LM, Reiter E, Robertson R, Friend J, McCann I, Skatun D, Donnan PT. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: Randomised controlled trial. Br Med J 2001: 322: 1396-1400. |
|
Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9: 531-541. |
|
Li R, Sonik A, Stindl R, Rasnick D, Duesberg P. Aneuploidy vs. gene mutation hypothesis of cancer: Recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci USA 2000; 97: 3236-3241. |
|
Lijinsky W. Statement in: Regulation of Food Additives and Medicated Animal Feeds. Hearings before a Subcommittee of the Committee on Government Operations, House of Representatives, 92nd Congress. Serial No.62-868, 7-167. Washington DC: U.S. Government Printing Office, 1971. |
|
Little CC. Statement in: Cigarette Labeling and Advertising - 1969. Hearings before the Committee on Interstate and Foreign Commerce, House of Representatives, 91st Congress. Serial No.91-12, 1104-1108. Washington DC: U.S. Government Printing Office, 1969. |
|
MacAskill A, Stead M, Mackintosh AM, Hastings G. "You cannae just take cigarettes away from somebody and no' gie them something back": Can social marketing help solve the problem of low-income smoking? Social Marketing Quarterly 2002; 8: 19-34. |
|
McConnell EM, Solleveld HA, Swenberg JA, Boorman GA. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI 1986; 76: 283-289. |
|
MRC 1957: Tobacco smoking and cancer of the lung: Statement by the Medical Research Council. Br Med J 1957; 1523-1524. |
|
Nasiell M, Auer G, Kato H. "Cytological studies in man and animals on development of bronchogenic carcinoma." In: McDowell EM (ed.), Lung Carcinomas. Edinburgh: Churchill Livingstone, 1987; 207-217. |
|
NCI 1978: Estimates of the fraction of cancer in the United States related to occupational factors. National Cancer Institute, National Institute of Environmental Health Sciences, National Institute for Occupation Safety and Health, 1978. |
|
Onuigbo WJB. The diagnosis of lung cancer in the 19th century. Brit J Dis Chest 1971; 65: 119-124. |
|
Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986; 76: 217-222. |
|
Passey RD. Some problems of lung cancer. Lancet 1962; 107-112. |
|
Passey RD, Holmes J McD. The incidence of intrathoracic neoplasia in the teaching hospitals of Great Britain 1894-1928. Q J Med 1935; 15: 321-344. |
|
Peto R, Doll R. The control of lung cancer. New Sci 1985; 105: 26-30. |
|
Peto R, Doll R. Smoking accepted on death certificates [letter]. Br Med J 1992; 305: 829-830. |
|
Pettit SJ, Seymour K, O'Flaherty E, Kirby JA. Immune selection in neoplasia: Towards a microevolutionary model of cancer development. Br J Cancer 2000; 82: 1900-1906. |
|
Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21: 7435-7451. |
|
Pike MC, Doll R. Age at onset of lung cancer: Significance in relation to effect of smoking. Lancet 1965; 1: 665-668. |
|
Pollack ES, Nomura AMY, Heilbrun LK, Stemmermann GN, Green SB. Prospective study of alcohol consumption and cancer. N Engl J Med 1984; 310: 617-621. |
|
Randall M, Kilpatrick KE, Pendergast JF, Jones KR, Vogel WB. Differences in patient characteristics between Veterans Administration and community hospitals: Implications for VA planning. Medical Care 1987; 25: 1099-1104. |
|
RCP 1962: Smoking and health: A report of the Royal College of Physicians of London on smoking in relation to cancer of the lung and other diseases. London: Pitman Medical Publishing Co Ltd, 1962. |
|
RCP 1971: Smoking and health now: A new report and summary on smoking and its effects from the Royal College of Physicians of London. London: Pitman Medical & Scientific Publishing Co Ltd, 1971. |
|
RCP 1977: Smoking or health: The third report from the Royal College of Physicians. London: Pitman Medical, 1977. |
|
RCP 2000: Nicotine addiction in Britain: A report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians, 2000. |
|
Rigdon RH. Statement in: Cigarette Labeling and Advertising - 1965. Hearings before the Committee on Interstate and Foreign Commerce, House of Representatives, 89th Congress. Serial No. 89-11, 599-604. Washington DC: U.S. Government Printing Office, 1965. |
|
Rigdon RH, Kirchoff H. A consideration of some of the theories relative to the etiology and incidence of lung cancer. Texas Rep Biol Med 1952; 10: 76-91. |
|
Robins J, Greenland S. The probability of causation under a stochastic model for individual risk. Biometrics 1989; 45: 1125-1138. |
|
Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-19. |
|
Rodin SN, Rodin AS. Human lung cancer and p53: The interplay between mutagenesis and selection. Proc Natl Acad Sci USA 2000; 97: 12244-12249. |
|
Roe FJC. The relevance and value of studies of lung tumours in laboratory animals in research on cancer of the human lung. Proc Third Quad Conf Cancer 1966; 101-126. |
|
Roe FJC, Salaman MH, Cohen J. Incomplete carcinogens in cigarette smoke condensate: Tumour-promotion by a phenolic fraction. Br J Cancer 1959; 13: 623-633. |
|
Rohwedder JJ, Weatherbee L. Multiple primary bronchogenic carcinoma with a review of the literature. Am Rev Respir Dis 1974; 109: 435-445. |
|
Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav 2000; 67: 71-81. |
|
Rosenblatt MB. The increase in lung cancer: Epidemic or artifact? Medical Counterpoint 1969; 1: 29-34, 37-39. |
|
Rosenow EC, Carr DT. Bronchogenic carcinoma. CA Cancer J Clin 1979; 29: 233-245. |
|
Rosenthal SR. Cancer precursors and their control by stimulation of the immune system. Biomed Pharmacother 1984; 38: 429-433. |
|
Rothman K, Greenland S. "Causation and causal inference." In: Rothman K, Greenland S (eds.) Modern epidemiology (2nd edn.). Philadelphia: Lippincott, Williams & Wilkins, 1998; 7-28. |
|
Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1996; 134: 466-470. |
|
Seltzer CC. Morphologic constitution and smoking. JAMA 1963a; 183: 639-645. |
|
Seltzer CC. Morphologic constitution and smoking [letter]. JAMA 1963b; 184: 1052. |
|
Seltzer CC. Constitution and heredity in relation to tobacco smoking. Ann NY Acad Sci 1967; 142: 322-330. |
|
Smithers DW. Facts and fancies about cancer of the lung. Brit Med J 1953: 1235-1239. |
|
Sommers SC. Statement in: Public Health Cigarette Amendments of 1971. Hearings before the Consumer Subcommittee of the Committee on Commerce, United States Senate, 92nd Congress. Serial No.92-82, 88-96. Washington DC: U.S. Government Printing Office, 1972. |
|
Sommers SC. Statement in: Cigarette Smoking and Disease, 1976. Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, 94th Congress. Washington DC: U.S. Government Printing Office, 1976; 268-279. |
|
Sommers SC. Statement in: Smoking Prevention Education Act. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, 98th Congress. Serial No.98-8, 438-442. Washington DC: U.S. Government Printing Office, 1983. |
|
Spain DM, Bradess VA, Tarter R, Matero A. Metaplasia of bronchial epithelium. JAMA 1970; 211: 1331-1334. |
|
Spielberger CD, Jacobs GA. Personality and smoking behavior. J Pers Assess 1982; 46: 396-403. |
|
Steiner PE. Etiological implications of the geographical distribution of lung cancer. Acta Unio Int Contra Cancrum 1953; 9: 450-475. |
|
Stewart HL, Herrold KM. A critique of experiments on attempts to induce cancer with tobacco derivatives. Bulletin de l'Institut International de Statistique 1962; 39: 457-477. |
|
Tokuhata GK. Cancer of the lung: Host and environmental interaction. Harrisburg: Pennsylvania Department of Health, 1972. |
|
Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963; 30: 289-312. |
|
Toyooka S, Tsuda T, Gazdar AF. p53 review article: The TP53 gene, tobacco exposure, and lung cancer. Hum Mutation 2003; 21: 229-239. |
|
TRC 1967: Tobacco Research Council. Review of Activities 1963-66. London: Tobacco Research Council, 1967. |
|
True WR, Heath AC, Scherrer JF, Waterman B, Goldberg J, Lin N, Eisen SA, Lyons MJ, Tsuang MT. Genetic and environmental contributions to smoking. Addiction 1997; 92: 1277-1287. |
|
UKHC 2000: The tobacco industry and the health risks of smoking. House of Commons Session 1999 - 2000, Second Report of the Health Committee: HC 27. London: The Stationery Office, 2000. |
|
UKWP 1998: Smoking Kills: A White Paper on Tobacco. Presented to Parliament by the Secretary of State for Health and the Secretaries of State for Scotland, Wales and Northern Ireland by Command of Her Majesty: Cm 4177. London: The Stationery Office, 1998. |
|
USSG 1964: Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington DC: US Department of Health, Education, and Welfare, Public Health Service, 1964. |
|
USSG 1971: The Health Consequences of Smoking: A Report to the Surgeon General. Washington DC: US Department of Health, Education, and Welfare, Public Health Service, 1971. |
|
USSG 1988: The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. Washington DC: US Department of Health and Human Services, Public Health Service, 1988. |
|
Van Rossum CTM, Shipley MJ, van de Mheen H, Grobbee DE, Marmot MG. Employment grade differences in cause specific mortality: A 25 year follow up of civil servants from the first Whitehall study. J Epidemiol Community Health 2000; 54: 178-184. |
|
Van Teijlingen E, Friend JAR. Children and smoking: The problem and the way forward. Thorax 1992; 47: 485-488. |
|
Wallack L. "Improving health promotion: Media advocacy and social marketing approaches." In: Atkin C, Wallack L (eds.) Mass communication and public health: Complexities and conflicts. California: Sage Publications, 1990; 147-163. |
|
Warburton DM. "The puzzle of nicotine use." In: Lader MM (ed), The Psychopharmacology of Addiction. Oxford: Oxford University Press, 1988a; 27-49. |
|
Warburton DM. Situational determinants of smoking. Pharmacopsychoecologia 1988b; 1: 67-77. |
|
Weller CV. The pathology of primary carcinoma of the lung. Arch Path 1929; 7: 478-519. |
|
Wells HG. Relation of clinical to necropsy diagnosis in cancer and value of existing cancer statistics. JAMA 1923; 80: 737-740. |
|
Wells CK, Feinstein AR. Detection bias in the diagnostic pursuit of lung cancer. Am J Epidemiol 1988; 128: 1016-1026. |
|
Willis RA. Pathology of tumours. London: Butterworth & Co. (Publishers) Ltd; 1948. |
|
Willis RA. The incidence and histological types of pulmonary carcinoma, with comments on some fallacies and uncertainties. Med J Australia 1961; 1: 433-440. |
|
Winternitz MC, Wason IM, McNamara FP. The pathology of influenza. New Haven: Yale University Press, 1920. |
|
Wynder EL. Laboratory contributions to the tobacco-cancer problem. Brit Med J 1959, 317-322. |
|
Wynder EL, Wright G. A study of tobacco carcinogenesis: I. The primary fractions. Cancer 1957a; 10: 255-271. |
|
Wynder EL, Kopf P, Ziegler H. A study of tobacco carcinogenesis: II. Dose-response studies. Cancer 1957b; 10: 1193-1200. |
|
Wynder EL, Graham EA, Croninger AB. Experimental production of carcinoma with cigarette tar: II. Tests with different mouse strains. Cancer Res 1955; 15: 445-448. |
|
Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risk in families of nonsmoking probands: Heterogeneity by age at diagnosis. Genet Epidemiol 1999; 17: 253-273. |
|
Yerushalmy J. "Statistical considerations and evaluation of epidemiological evidence." In: James G, Rosenthal T (eds.): Tobacco and health. Springfield, Illinois: Charles C Thomas, 1962; 208-230. |
|
Yerushalmy J. Infants with low birth weight born before their mothers started to smoke cigarettes. Am J Obstet Gynecol 1972; 112: 277-284. |
(3) Passages in documents not put to witnesses
[1.35] The documentary productions, as I have said, extend to many thousands of pages. Most of them are non-legal publications, of which there are many hundreds, including those in the list of references. At the proof, passages from only some of these publications were put to witnesses. It is open to question whether all of these passages were adopted by the witnesses to whom they were put, and thus became part of their evidence. Leaving that aside for later discussion, I feel obliged to say something at this stage about the question whether it is open to me to take into account any passage in any publication which was not put to any witness.
[1.36] The matter arose in this way. As will be seen, the presentation of the pursuer's case depended to a large extent on reliance on published reports. As Mr McEachran made a point of bringing out, some of these reports extended to hundreds of pages. At the hearing on evidence, he sought to draw to my attention various passages in these reports, some of which had been put to witnesses, and some of which had not. Mr Jones submitted that I should not take notice of any passage which had not been put to a witness. When I took this up with Mr McEachran, he said that he did not agree with the submission that I could only have regard to those passages which were expressly referred to in the evidence. This might be so, he said, where a matter was in dispute between the parties, but not where, as here, ITL's position was that they "just do not know", in particular that cigarette smoking can cause lung cancer. I asked Mr McEachran whether he was saying that it was open to me to pick up any of the reports that he had referred to and rely on any passage that happened to catch my attention. Mr McEachran said that I was entitled to read it, because otherwise I could not make sense of the whole thing. In a situation where ITL were not seeking to set up another case, that lung cancer was not caused by smoking but by something else, I was entitled, he submitted, to look at these documents more widely: "Otherwise, we would be here forever, if we have to go through 600 pages of every document. There has to be some realism about this." There was not an absolute bar to doing this in a situation where the parties had not led evidence which was totally contradictory. In a situation where the other side were not trying to prove the opposite, a witness was entitled to say that he adopted the terms of the full publication.
[1.37] I reject this approach. With a few well-recognised exceptions, the terms of a document which has been lodged as a production are not evidence. There are procedures, such as the joint minutes and notices to admit which have been used in this case, under which the terms of a document may be agreed to be accurate, and in such an event is not necessary for it to be put to any witness. Otherwise, evidence is required to establish its terms. I do not regard it as being open to me to take account of any passage in any document, the terms of which were not agreed, and to which reference was not made in the course of the evidence of any witness. This is because of the fundamental rule that I must decide the case on the basis of the evidence led before me, leaving aside any other considerations. It would risk doing a serious injustice if I were to allow myself to be influenced by, for example, my reading of further chapters in a textbook, other than those to which reference had been made in the course of evidence, just as it would be if I were to read letters in a correspondence file which had not been put to any witness. I refer also to the second passage from the opinion of the Lord President in Davie v Magistrates of Edinburgh, quoted at para.[5.5]. Accordingly, when I come to discuss the evidence, I propose to confine my consideration to those passages in the literature to which express reference was made.
[1.38] The views expressed in the preceding paragraph do not depend on the position of ITL, which I discuss in Part III, in particular on the question whether cigarette smoking can cause lung cancer. For reasons given there, the burden of proof of this averment is on the pursuer, regardless of what may or may not have been said by or on behalf of ITL on other occasions and must be discharged in accordance with the normal rules of evidence.
(1) The position of the pursuer
[2.1] Mr McEachran introduced his submissions on the positions of the parties by saying that it was a tribute to the steadfastness and resolution of Mrs McTear that she had persevered over all these years to get this case into court and to await my judgment. This was in spite of all the "pressure" ITL had "thrown at her", their constant objections to her application for legal aid and, in particular, the way they tried to make her put up "security for costs" (i.e. caution for expenses) in the figure of Ł2 million. Mr McTear said in evidence "cigarette companies are simply selling poison to make money". This gave one of the reasons as least why he felt strongly enough to bring an action. Mrs McTear gave evidence that this became his purpose and she hoped that it would become his great achievement. It was clear that Mrs McTear was fond of her husband, errant though he was, and was proud that at the end he was "prepared to challenge the big battalions".
[2.2] It is averred by the pursuer that:
1. Cigarette smoking can cause lung cancer, and the World Health Organization, the United Kingdom Government and the United States Government have accepted for many years that cigarette smoking can cause lung cancer.
2. Mr McTear's lung cancer was caused by his smoking.
3. When Mr McTear commenced smoking in 1964 he was unaware that smoking could cause fatal diseases.
4. Tobacco is addictive, "in the sense that once individuals such as [Mr McTear] have started smoking it is difficult for them to wean themselves off the habit".
5. After commencing smoking Mr McTear quickly became addicted to cigarettes, so that when in about 1971, following the appearance of Government health warnings on cigarette packets, he became aware of the risks to health caused by smoking, he was unable to give up smoking, despite attempts to do so, because of his addiction.
The pursuer relies in particular, in support of points 1 and 4, on a series of reports and similar publications which, in chronological order, are MRC 1957, RCP 1962, USSG 1964, RCP 1971, USSG 1971, RCP 1977, IARC 1986, USSG 1988, UKWP 1998, RCP 2000, UKHC 2000 and IARC 2004.
[2.3] Counsel submitted that this was a straightforward product liability case. In Donoghue v Stevenson 1932 S.C. (H.L.) 31 it was decided that a manufacturer was under a duty to take reasonable care for the consumers of his products. If he knew of a health risk involving death, it was his duty to cease production until the problem was dealt with. From the 1950s, there had been reports in the media that doctors had claimed that there were health risks associated with tobacco smoking. By 1957 at least, the tobacco industry and ITL were aware of the health risks from tobacco smoking and accordingly the duty arose then to cease manufacture. If they had done this Mr McTear would not have developed lung cancer because of ITL's products. There would have been none of ITL's products for him to have smoked.
[2.4] On a broad overview of the case, "standing back and trying to see the wood from the trees" and separating the essentials from the days of detailed evidence, counsel submitted:
"It respectfully seems to me that this case is relatively straightforward, although I think it is the first case of its type against the tobacco industry in the UK. There should not be much need for the court to go into much of the detailed evidence in the way of articles and things."
As will be seen, this approach has not found favour with me; though no doubt, if it had, I might have spared myself, and the reader, many hundreds of the pages which follow.
[2.5] When I asked Mr McEachran why, if all the facts necessary to establish liability were present from the late 1950s and at all material times thereafter, there had been no instance in the United Kingdom of a successful action against a tobacco manufacturer based on grounds similar to those in the present case, Mr McEachran submitted that this was attributable to the power of the tobacco industry. "It is the little man against the big battalions." They were a very well-funded industry who were able to fight off attacks. This was how they had obtained the exemption for tobacco under section 10 of the Consumer Protection Act 1987.
[2.6] In response to this, Mr Jones told me about the position in England. He said that in the summer of 1992 solicitors acting for plaintiffs placed advertisements in two newspapers inviting any persons who believed themselves to be suffering from illnesses caused by smoking to get in touch with them with a view to investigating the possibility of pursuing claims against various tobacco companies on their behalf. As a result, over the course of the next three months or so, some 300 people approached one or other of two firms of solicitors, and applications for legal aid were made on their behalf. In January 1995 the Legal Aid Board made a limited grant of legal aid for a full review of merits, quantum and the total likely costs involved in pursuing an action against the tobacco companies. This was undertaken by the applying solicitors, and the Board then took independent advice from leading counsel. In July 1996 all the applications were refused, the refusal being expressed to be on the merits. In the late summer of 1996 two firms of solicitors offered to fund claims against tobacco companies on behalf of a number of lung cancer sufferers under conditional fee arrangements. Following this, a cohort of about fifty-two plaintiffs who had all suffered lung cancer issued writs in England. Ten of these were selected to act as lead plaintiffs. Of these, it was accepted that eight had not commenced proceedings timeously, having regard to the English law of limitations. They were required to apply to the court to exercise discretionary powers to dispense with the limitation period. Trial of limitation issues was heard before Wright J in 1998, and in February 1999 he refused the applications. Of the fifty-two cases, all but seven dismissed of consent in March 1999. In April 1999 four of the remaining seven cases were also dismissed of consent. The court refused to exercise discretionary powers to dispense with the limitation period in the remaining three cases.
(2) The position of ITL
[2.7] ITL admit that the World Health Organization, the United Kingdom Government and the United States Government have accepted for many years that cigarette smoking can cause lung cancer, that Government health warnings first appeared on cigarette packets in 1971, and that they were aware of the publications relied upon by the pursuer. Otherwise they deny the foregoing averments. They aver that:
1. Cigarette smoking has not been scientifically established as a cause of lung cancer and, although various theories have been advanced, the cause or causes of lung cancer are unknown and the mechanism or mechanisms whereby lung cancer develops are unknown.
2. Smoking is correctly described as a habit and not an addiction, and while some smokers may find it difficult to stop smoking, smokers who choose to stop smoking are able to do so.
3. Assuming that Mr McTear commenced smoking in 1964, he did so against the background of general public awareness that there were health risks associated with smoking, and in particular general public awareness of the view that smoking could cause lung cancer.
4. At all relevant times the public at large understood that some smokers might find it difficult to stop smoking, and Mr McTear shared this understanding.
[2.8] Mr McEachran submitted that, having regard to the pleadings for ITL and to the position adopted by them over the years, to the effect that that it was not known whether cigarette smoking caused lung cancer, my approach to this factual issue should be different from what it would be if they not only denied that cigarette smoking could cause lung cancer but offered to prove a contrary case.
[2.9] This requires consideration of matters raised principally in the evidence of Mr Gareth Davis, Chief Executive Officer (CEO) of Imperial Tobacco Group plc. Before he was called as a witness, however, the scene was set in the evidence of three of the expert witnesses for the pursuer, Professor Sir Richard Doll, Professor Friend and Professor Hastings. An account of the first of these appears before that of Mr Davis, of the other two after it.
ITL's position before the House of Commons Health Committee
[2.10] Discussion of the position of ITL, as explained by Mr Davis, is more readily understood if I give a brief outline now of proceedings before the Health Committee of the House of Commons in 2000, as set out in UKHC 2000, Vol.II. This was brought out in somewhat fragmentary form in the examination-in-chief of Mr Davis. Prior to a hearing before the Committee on 13 January 2000 written memoranda of evidence were submitted by British American Tobacco, Gallaher Group plc, Imperial Tobacco Group plc, Philip Morris Europe SA and RG Reynolds Tobacco (UK) Ltd. Oral Evidence was given at the hearing by representatives of each of these companies. Mr Davis gave evidence as CEO of Imperial Tobacco Group plc.
[2.11] On 14 January 2000 the Clerk of the Committee wrote to each of these five companies asking for supplementary written evidence in response to five questions. One question was:
"Does smoking cause lung cancer, heart and circulation disease and respiratory illnesses, such as emphysema - 'cause' meaning that smoking is an activity that results in there being more lung cancer, heart and circulation disease and respiratory illness related deaths than there would otherwise be - other things being equal?"
In a letter dated 20 January 2000 the Corporate Affairs Director of Imperial Tobacco Group plc replied to this question:
"Imperial accepts that cigarette smoking may be a cause of lung cancer, cardiovascular disease and respiratory diseases, such as emphysema, and that cigarette smokers are more likely to develop these diseases than non-smokers. However, Imperial does not know whether or not there would be fewer deaths from these diseases in the absence of cigarette smoking."
The other four tobacco companies answered this question more or less in the affirmative. Another question was "Does your company believe that nicotine is addictive by reference to each of these criteria: (a) DSM-IV; (b) ICD-10?"
The reply to this question in the same letter was:
"We agree that nicotine could be regarded as addictive by reference to DSM-IV and ICD-10 but this does not mean that smokers are unable to stop smoking if they choose to do so."
[2.12] Under the heading "Research materials" the Corporate Affairs Director referred to a request by the Committee to Mr Davis to send them the documents from scientists and doctors employed by Imperial which had led Imperial to the conclusions which he communicated to the Committee. The letter continued:
"Our views on smoking and health are based on monitoring of the scientific literature, attending scientific conferences and meetings with and advice from external scientists. We maintain a substantial collection of smoking and health documents, consisting of articles from the scientific literature and other published material, and we are willing to furnish you with copies of these documents. However, we imagine that that may not assist the Committee both because they are readily available from other sources and because of their volume. The advice given by external scientists was not given in writing. If the Committee would find it helpful in its deliberations, we would be willing to ask the external scientists, who have advised us, to summarise their views and conclusions regarding smoking and health issues in writing."
[2.13] The letter concluded:
"The scientific issues which lie behind your questions are complex and answers can only be given on the basis of an exercise of judgment. Imperial's views on these issues reflect the judgment of the scientists whose advice it has received.
We agree that smoking may be a cause of disease. We recognise that other scientists and public health authorities have formed the judgment that smoking is a cause of certain diseases. This has been the consistent public health message for decades. We agree that there should be one consistent public health message. This is why, whatever our views on these complex issues, Imperial does not challenge the public health message. It has not done so for almost forty years and intends, in the future, to continue its policy of not challenging the public health message that smoking causes these diseases."
[2.14] Further oral evidence was given by the same five witnesses at a hearing of the Health Committee on 27 January 2000. In his evidence before the Committee, and again in his evidence before me, Mr Davis confirmed that the position of ITL was as set out in the passages from the letter dated 20 January 2000 quoted above.
Professor Sir Richard Doll
[2.15] The first substantive matter about which Sir Richard Doll (whose CV is set out at para.[5.189]) was asked was set out in a letter by him dated 8 September 1997 to Mrs McTear's Glasgow solicitor, Mr Cameron Fyfe. It related to a meeting which took place in London sometime between 1962, when RCP 1962 was published, and 1966, when Sir Richard started an investigation based on something that was said at the meeting. At the meeting there were the members of the Royal College of Physicians Committee on Smoking and Atmospheric Pollution, who had produced RCP 1962, and a couple of representatives of the tobacco industry. At that time ITL were the major tobacco company in the United Kingdom. They were represented at the meeting. There was a discussion about how the tobacco industry would react to the conclusions of RCP 1962. The tobacco industry representatives agreed that they would not contest the idea that cigarette smoking caused cancer of the lung, but said that they would continue selling their product because, in their view, it gave people pleasure. In the letter he wrote:
"You have only my word for it that the representative of the industry at the above meeting (I am not sure how many representatives were present, but there was certainly one) accepted the causal link between smoking and lung cancer and stated that the industry had agreed not to attempt to deny the causal link publicly."
He had, however, he said, other evidence that this was the case.
[2.16] First, Geoffrey Todd, the statistician to the tobacco industry, had from 1950 onwards tried to disprove the link. He came and discussed the evidence with Professor Bradford Hill and Sir Richard early in the 1950s. He produced several papers trying to disprove the relationship, but he finally came to the conclusion that they were correct, that cigarette smoking did cause cancer of the lung. He told the industry and, as a result, they concluded his contract. Sir Richard remembered this very well because Geoffrey Todd took Sir Richard and his wife out for dinner at a hotel in London and said that this was the last time he would have an expense account, as he was losing his job. A few days later he rang up and said that the tobacco industry had agreed to take him back on his own terms: namely, that they would accept that cigarette smoking caused lung cancer. So he went back to work for them for several more years. He would not work for them unless they accepted that cigarette smoking could cause lung cancer; he said that the evidence was so clear that he could not go on working for them unless they accepted that as the basis. This was in the early 1960s, Sir Richard could not say precisely when. Geoffrey Todd was, he thought, Secretary of the Tobacco Research Council, which had been formed by the members of the tobacco industry, including ITL.
[2.17] Secondly, this was confirmed by Professor Charles Fletcher in Fletcher 1992. He was a physician who worked at the Hammersmith Postgraduate Medical School and had done a lot of research initially into pneumoconiosis but became increasingly interested in smoking. He was a member of and Honorary Secretary to the committee which produced RCP 1962, which he edited. According to Fletcher 1992 he was instrumental, with others, in setting up the campaigning body ASH in 1971. During the interview Fletcher referred to Sir Richard's work on smoking and lung cancer. Sir Richard said that he started doing this work in 1947, and was paid to do it from 1948. This led in the first place to the publication of Doll and Hill 1950. Not so many people were interested in smoking, but there were a number of people interested in epidemiology. English epidemiologists were setting the international scene, and a lot of them were invited to go out and set up departments in America. Sir Richard did not agree with Fletcher's statement that epidemiology was really not regarded as part of medicine, but he said that it was not understood by physicians. Some of the leading physicians at the time embraced epidemiology, but it had not been understood by 90% of working doctors. Sir Richard agreed with Fletcher's remarks that the initial reaction to Doll and Hill 1950 was disbelief, in general, apart from some of the leading people like Sir Harold Himsworth of the MRC. The Medical Research Council's response to requests from the Government to advise them as to what were the causes of the increased mortality from lung cancer was MRC 1957.
[2.18] Fletcher 1992 mentioned the background to the formation of the Royal College of Physicians Committee. Fletcher had approached Sir Robert Platt, the President of the College, who agreed that it should produce a report on smoking and Fletcher suggested that he should invite Avery Jones, Guy Scadding and Bodley Scott to join it. Sir Richard said that Avery Jones was the leading gastroenterologist in the UK and a man with whom he had begun epidemiological research on the causes of gastric and duodenal ulcer in 1947. Guy Scadding was a respiratory physician and was the best doctor Sir Richard had ever known. Bodley Scott was a very well known haematological physician with a special interest in blood disease.
[2.19] According to Fletcher 1992 he was largely responsible for drafting RCP 1962. He had in mind the average Member of Parliament as the audience for this report. The response of the politicians was one of neglect. Enoch Powell was Minister of Health and he accepted the conclusions of the report. Asked what was the response of the tobacco industry, Fletcher said:
"That brings in Geoffrey Todd, who had been dismissed from his post as public relations officer with the tobacco manufacturers when he told them he accepted that smoking caused lung cancer. But they missed his administrative skills so much that they re-appointed him. He wrote to me before the report was published and said that he would like 20 copies to distribute to the main manufacturers because he wanted to insist that they took the issue seriously. Later the manufacturers set up a research division directed by Todd, which financed some of my work at Hammersmith. John Partridge, Chairman of Imperial Tobacco, accepted the evidence but was sure their scientists would be able to find a way of removing the cancer producing substance from the smoke."
Fletcher agreed that the tobacco industry's initial response was that they accepted the evidence but h